« Varsavsky says he will bring FON to Miami | Main | SCORE’s simple steps for starting a business »

News: Biscayne Pharmaceuticals receives $1.5M in funding

Biscayne Pharmaceuticals, a company that uses the discoveries of Miami Nobel Prize-winner Andrew Schally, announced it has received $1.5 million in financing to develop growth hormone-releasing hormone (GHRH) drugs.

Schally, the Distinguished Leonard M. Miller Professor of Pathology & Professor of Hematology and Oncology at the University of Miami Miller School of Medicine, is working with Joshua M. Hare, a Biscayne co-founder who is the Louis Lemberg Professor of Medicine in the University of Miami Health System, to develop the GHRH technology for coronary heart disease.

The financing was led by the Reich Group, a Miami Beach investment firm. Managing partner Samuel Reich, formerly with Acuity Pharmaceuticals and OPKO Health, is becoming Biscayne’s chief executive and chairman of the board.

Biscayne’s technology is licensed from the University of Miami, the company said in a press release.

-- JOHN DORSCHNER

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.